Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Innovative Otago health research gains funding

Innovative Otago health research gains funding


Four University of Otago researchers have gained a total of around $550,000 to support their innovative studies in the latest funding announcement by the Health Research Council of New Zealand (HRC).

Two of the three 2014 HRC Explorer Grants have been awarded to Professor Greg Cook (Microbiology & Immunology) and Associate Professor John Reynolds (Anatomy) for projects aiming to overcome antibiotic resistance and revolutionise treatment of Parkinson’s disease, respectively.

Explorer grants are intended to advance ideas considered to be transformative, innovative, exploratory or unconventional, and have potential for major impact.

Professor Julian Crane (Medicine, Wellington) and Associate Professor Bob Hancox (Preventive and Social Medicine) gained HRC Feasibility Studies Awards to glean critical practical information needed for their investigations to progress towards fundable projects.

Professor Crane is studying the potential of a seaweed extract called Carrageenan to be topically used in the nose to prevent the common cold, while Associate Professor Hancox is focusing on determining whether beta-blockers may actually be a safe and effective treatment for Chronic Obstructive Pulmonary Disease (COPD).

Professor Cook’s Explorer grant will support him to develop novel antibiotics that aim to transform the way we treat bacterial infections and combat multi-drug-resistant bacteria.

The World Health Organization (WHO) recently released its first global report on antibiotic resistance, revealing it as a serious, worldwide threat to public health.

In contrast to current antibiotic targets such as the cell wall, and protein and DNA synthesis, Professor Cook’s team have developed new antibiotics that target the part of all living cells that produce energy. These new antibiotics or ‘metabiotics’, so-called because they target a metabolic process, will help the medical community keep pace with the growing problem of bacterial resistance to antibiotics.

Professor John Reynolds will use his Explorer Grant to demonstrate the effectiveness of a new drug delivery system that he and his team have designed for restoring brain function in patients with neurological diseases such as Parkinson’s disease.

The system mimics normal neuro-chemical signalling in the brain. The researchers aim to reinstate the missing dopamine signal in Parkinson’s disease (PD) by activating the release of dopamine-like drugs from biological carriers in targeted brain areas at natural timing. They aim to restore movement in a PD model without the debilitating side effects associated with current dopamine-replacement therapies.

Ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news